Tsingke Biotech Showcased AI-Powered Biomanufacturing Solutions at 2025 Festival of Biologics

"The boundary between research and manufacturing is fading — scientists are validating manufacturability in the lab, while industry adopts results faster than ever," said Nan Zhang, Marketing Manager of Tsingke Biotech. "The boundary between research and manufacturing is fading — scientists are validating manufacturability in the lab, while industry adopts results faster than ever," saidNan Zhang, Marketing Manager of Tsingke Biotech. Tsingke's Perspective: FromGene Synthesisto...
Comunicato Precedente

next
Comunicato Successivo

next
BEIJING, (informazione.news - comunicati stampa - scienza e tecnologia)

"The boundary between research and manufacturing is fading — scientists are validating manufacturability in the lab, while industry adopts results faster than ever," said Nan Zhang, Marketing Manager of Tsingke Biotech.

Tsingke's Perspective: From Gene Synthesis to Scalable Manufacturing

As a full-stack Gene Factory, Tsingke Biotech demonstrated capabilities spanning DNA/RNA synthesis, antibody expression, and nucleic acid process development. Its integrated platform connects discovery with scalable production, enabling a smooth transition from innovation to industrial manufacturing.

Tsingke's Capabilities:

Together, these capabilities position Tsingke to respond to emerging trends and advance next-generation biologics.

Guided by its vision, "The Great Tsingke Gene Factory," the company advances biomanufacturing through automation, digital design, and precision synthesis. "The Festival of Biologics bridges scientific breakthroughs and industrial application," added Nan Zhang.

Tsingke Biotech Showcased AI-Powered Biomanufacturing Solutions at 2025 Festival of Biologics

About Tsingke

Beijing Tsingke Biotech Co., Ltd. is a leading biotechnology company providing comprehensive solutions for research and therapeutic development. With expertise in molecular biology, genetics, and protein science, Tsingke offers custom DNA/RNA synthesis, gene cloning, protein expression, antibody discovery, and viral vector packaging (AAV, LV, AdV). Its ISO 13485–certified facilities and Class 100,000 cleanroom ensure consistent quality and reliability. Backed by advanced automation and a global scientific team, Tsingke accelerates innovation in drug discovery, functional genomics, and genetic engineering—empowering researchers worldwide with cutting-edge biomanufacturing solutions.

For news and updates, follow Tsingke Biotech on LinkedIn.

Contact: market@tsingke.com.cn 

Photo - https://mma.prnewswire.com/media/2804421/e80a1bb8bacf3baf335fcd3cba83ab1.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/tsingke-biotech-showcased-ai-powered-biomanufacturing-solutions-at-2025-festival-of-biologics-302593768.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;